Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ChromaDex - Nutraceuticals World

What are you searching for?

Sign in

Search by

COMPANY SPOTLIGHT

ChromaDex

Company Headquarters

10900 Wilshire Boulevard, , Suite 600, Los Angeles, CA, 90024, US

Driving Directions Phone: View Phone
View website

Request more information from ChromaDex

Request more information from ChromaDex

Categories from ChromaDex

Herbs & Botanicals

spirulina

Vitamins

Related Content

Market Updates

Yasmeen Nkrumah-Elie, PhD, Receives First CRN/Radicle Science Trailblazing Woman Award

Nkrumah-Elie, global director for external research at ChromaDex, was honored for her commitment to advancing science, diversity, and female leadership.

By: Mike Montemarano

Chromadex Launches Niagen+ NAD+ Test Kit

The new test kit, available to healthcare practitioners, utilizes dried blood spot assay technology, which Chromadex reports is most suitable for accuracy.

By: Mike Montemarano

Research

Chromadex’s Niagen NR Tested in Phase 1 Parkinson’s Study

The NAD+ booster was well-tolerated at up to 3,000 mg/day, and improved the clinical severity of symptoms in 20 Parkinson’s disease patients.

By: Mike Montemarano

Research

Nicotinamide Riboside Treatment Linked to Improved Coordination in AT Patients: Prospective Study

In the longest trial to date on NR, ChromaDex’s Niagen improved coordination and eye movement in a small group of AT patients.

By: Mike Montemarano

Products & Ingredients

Zesty Paws and ChromaDex Launch Healthy Aging Nutraceuticals for Dogs

The new chews contain ChromaDex’s Niagen nicotinamide riboside, an NAD+ precursor.

By: Mike Montemarano

NAD+ and Aging: ChromaDex CEO Rob Fried Discusses Science, Industry Challenges and Expectations

The company’s flagship product Tru Niagen brought in nearly $70 million in sales last year.

By: Sean Moloughney

Market Updates

ChromaDex Partners with MyPharma2Go for Brazilian Distribution

Brazil will now be the first Latin American country to have Tru Niagen available on its market.

By: Mike Montemarano

Products & Ingredients

ChromaDex Launches Tru Niagen Immune

Supplement contains patented NR, plant-based vitamin D3, two forms of zinc, vitamin C produced via fermentation and an absorbable form of curcumin.

Research

Chromadex Announces New Preclinical Findings for Niagen

Preliminary trials evidenced the NAD+ supplement’s potential to hold protective benefit against degenerative conditions.

By: Mike Montemarano

Regulations

ChromaDex R&D Facility Earns ISO/IEC 17025:2017 Accreditation

This quality management certification represents full compliance with the most rigorous ISO quality standards for labs of this kind.

By: Mike Montemarano

Research

ChromaDex Highlights The Latest Research on Niagen

The patented nicotinamide riboside ingredient is being evaluated for applications including obesity, neurological protection, and immune response to COVID-19.

By: Mike Montemarano

Products & Ingredients

ChromaDex Partners with Persona Nutrition

Company expands global partnership with Nestlé Health Science.

Market Updates

ChromaDex Introduces Line of Cannabinoid Reference Standards

Materials can be used by research and testing community as benchmarks to confirm the identity and potency of products.

Regulations

ChromaDex Gains TGA Approval for Nicotinamide Riboside Chloride in Australia

Company receives market exclusivity for two years as it expands presence in the Asia-Pacific region.

Market Updates

ChromaDex and Nestlé Enter Global Commercial License and Supply Agreement for TRU NIAGEN

Deal includes global commercial license and supply agreement for sales of TRU NIAGEN for products in the medical nutrition and consumer health categories.